ArticleJournal of neurology2022
Individualized regimen of low-dose rituximab monotherapy for new-onset AChR-positive generalized myasthenia gravis.
Ying Du et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it